GlassScriptPhysician profile
Mary E Ostrowski
NPI 1497914709
$7,995.62
in general payments reported to CMS, 2019-2025
51 companies · $2,056 in 2025
The $2,056 reported for 2025 was more than what 94% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $890 · 2022: $1,639 · 2023: $1,917 · 2024: $1,494 · 2025: $2,056.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,399 · Education: $67.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,398.71 |
| Education | $67.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,398.75 | 2022-2025 | |
| Lilly USA, LLC | $555.69 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Glaxosmithkline, LLC. | $511.74 | 2022-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Novo Nordisk INC | $455.74 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $409.66 | 2021-2025 | Xifaxan |
| Medtronic, INC. | $304.71 | 2021-2025 | Symplicity G3, Intellis Adaptivestim, Corevalve Evolut R |
| Astrazeneca Pharmaceuticals LP | $277.65 | 2023-2025 | Airsupra, Farxiga, Breztri |
| Dexcom, INC. | $244.75 | 2024-2025 | Dexcom G6 Transmitter |
| Amgen INC. | $241.09 | 2021-2025 | Evenity, Prolia, Otezla |
| Exact Sciences Corporation | $239.71 | 2023-2025 | Cologuard Collection Kit |
| Abbott Laboratories | $231.56 | 2021-2025 | Freestyle Libre 3, Proclaim |
| Astellas Pharma US INC | $225.50 | 2021-2025 | Veozah |
| Pfizer INC. | $204.75 | 2023-2025 | |
| Boston Scientific Corporation | $203.22 | 2021-2023 | Watchman Flx |
| Takeda Pharmaceuticals U.S.A., INC. | $189.58 | 2022-2023 | Trintellix |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Ostrowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.